{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-074256","form_type":"8-K","ticker":"HSDT","cik":"0001610853","company_name":"Solana Co","filed_at":"2023-06-23T23:59:59+00:00","discovered_at":"2026-05-14T18:03:39.660983+00:00","generated_at":"2026-06-13T18:06:14.054897+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Helius Medical enters $1.95M ATM equity offering with Roth Capital","bullets":["Company signed Sales Agreement with Roth Capital to sell up to $1.95M of Class A common stock at market prices.","Roth Capital will receive 3.0% commission on gross proceeds from any sales under the at-the-market offering.","Offerings will be made under an existing S-3 registration statement effective May 26, 2023.","Company is not obligated to sell any shares; either party may suspend or terminate the offering.","Net proceeds are expected to be used for general corporate purposes."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-074256","json":"https://secwatch.observer/filing/0001104659-23-074256.json","markdown":"https://secwatch.observer/filing/0001104659-23-074256.md","text":"https://secwatch.observer/filing/0001104659-23-074256.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1610853/000110465923074256/0001104659-23-074256-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1610853/000110465923074256/tm2319490d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T18:06:14.054897+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1fc00a8974373f019d6dc22781202b6fce466eee","claim":"Solana Co entered into Sales Agreement with Roth Capital Partners, LLC valued at up to $1.95 million (effective 2023-06-23).","evidence_excerpt":"On June 23, 2023, Helius Medical Technologies, Inc. (the “Company”) entered into a Sales Agreement (the “Sales Agreement”) with Roth Capital Partners, LLC, as agent (the “Sales Agent”). Pursuant to the Sales Agreement, the Company may offer and sell up to $1.95 million in shares of Class A common stock, par value $0.001 per share (the “Shares”), from time to time through the Sales Agent.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1610853/000110465923074256/0001104659-23-074256-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"atm program"},{"label":"Counterparty","value":"Roth Capital Partners, LLC"},{"label":"Value","value":"up to $1.95 million"},{"label":"Effective","value":"2023-06-23"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}